RETRACTED: Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial

Eur J Obstet Gynecol Reprod Biol. 2016 Mar;198:100-104. doi: 10.1016/j.ejogrb.2016.01.015. Epub 2016 Jan 13.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editorial Board for the following reason: This single-author publication which reports the conducting of a large 3-arm randomised controlled trial, with no missing data from 210 recruited patients, has been questioned as implausible. The authors have been unable to provide supporting documents to provide an explanation.

Trial registration: ClinicalTrials.gov NCT02089620.

Keywords: Calcium supplements; Drospirenone; Oral contraceptive pills; PMS treatment; Premenstrual syndrome.

Publication types

  • Randomized Controlled Trial
  • Retracted Publication

MeSH terms

  • Adult
  • Androstenes / therapeutic use*
  • Calcium / therapeutic use*
  • Contraceptives, Oral, Combined / therapeutic use*
  • Double-Blind Method
  • Female
  • Humans
  • Premenstrual Syndrome / diagnosis
  • Premenstrual Syndrome / drug therapy*
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Androstenes
  • Contraceptives, Oral, Combined
  • drospirenone
  • Calcium

Associated data

  • ClinicalTrials.gov/NCT02089620